AGREEMENT, made this day of , 20 , between Corcept Therapeutics Incorporated, a Delaware
corporation (the “Company”), and (the “Indemnitee”).
W I T N E S S E T H :
WHEREAS, the Indemnitee is a director and/or officer of the Company.
WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors
or in other capacities unless they are provided with adequate protection through insurance or adequate indemnification against
inordinate risks of claims and actions against them arising out of their service to and activities on behalf of the corporation.
WHEREAS, in recognition of Indemnitee’s need for substantial protection against personal liability in order to
enhance Indemnitee’s continued service to the Company in an effective manner and Indemnitee’s reliance on the provisions of
the Company’s Certificate of Incorporation (“Certificate of Incorporation”) and the Company’s Bylaws (the “Bylaws”) requiring
indemnification of the Indemnitee to the fullest extent permitted by law, and in part to provide Indemnitee with specific
contractual assurance that the protection promised by such Certificate of Incorporation and Bylaws will be available to
Indemnitee (regardless of, among other things, any amendment to or revocation of such Certificate of Incorporation or Bylaws
or any change in the composition of the Company’s Board of Directors or acquisition transaction relating to the Company), the
Company wishes to provide in this Agreement for the indemnification of and the advancing of expenses to Indemnitee to the
fullest extent (whether partial or complete) permitted by law and as set forth in this Agreement.
WHEREAS, the Certificate of Incorporation, the Bylaws and the General Corporation Law of the State of Delaware
(“DGCL”) expressly provide that the indemnification provisions set forth therein are not exclusive and thereby contemplate that